Insulin resistance and its relation to inflammatory status and serum lipids among young women with PCOS
Keywords:
Polycystic ovarian syndrome, Insulin resistance, C-reactive proteinAbstract
Background: The incidence of polycystic ovarian syndrome (PCOS) is increasing among young women. PCOS women have decreased insulin sensitivity independent of body mass index with increase in lipid levels. Studies on measuring inflammatory status in PCOS showed varying results. The inter-relationship between inflammatory status, insulin resistance and lipid levels among PCOS women was studied.
Methods: Twenty PCOS women and 20 healthy controls of age 18-25 years were recruited. Fasting blood samples were collected for estimation of serum glucose, insulin levels, lipid levels and C-reactive protein (CRP) concentration. Insulin resistance was determined by homeostasis model assessment (HOMA-IR) index.
Results: PCOS women had significant increase in fasting insulin, HOMA-IR and triglycerides compared to healthy controls. HOMA-IR was positively associated with serum triglycerides, VLDL levels and CRP levels among PCOS subjects. Total Cholesterol was positively associated with CRP. Regression analysis showed HOMA-IR as a sole parameter strongly linked with PCOS women. This indicates that, IR is an independent pathogenic variable linked with PCOS which in turn showed positive association with CRP and triglycerides.
Conclusion: IR is the hallmark of PCOS among young adolescent women. IR is associated with elevated CRP and triglyceride levels. Taking measures to increase insulin sensitivity, may help in altering dyslipidemia and inflammatory status, thereby reducing CVD risk among young women with PCOS.
References
Padubidri VG, Daftary SN. Disorders of the Ovary and Benign Tumours. In: Howkins and Bourne eds. Shaws textbook of gynaecology. 15th ed. Haryana, India: Elsevier Publication; 2011:369-70.
Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol 2011;24(4):223-7.
Allahbadia GN, Merchant R. Polycystic ovary syndrome in the Indian Subcontinent. Semin Reprod Med 2008;26(1):22-34.
Dunaif A. Insulin resistance and polycystic ovary syndrome: mechanism and implication for pathogenesis. Endocr Rev 1997;18960:774-800.
Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome–a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007;92(12):4546-56.
Flavia Tosi, Romolo Dorizzi, Roberto Castello, Claudio Maffeis, Giovanna Spiazzi, iacomo Zoppini, Michele Muggeo and Paolo Moghetti. Body fat and Insulin Resistance independently predict increased serum C-Reactive protein in hyperandrogenic women with polycystic ovary syndrome. Eur J Endocrinol 2009;161(5):737-45.
Boulman N , Levy Y, Leiba R, Shachar S, Linn R, Zinder O and Blumenfeld Z.Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: a marker of cardiovascular disease. J Clin Endocrinol Metab 2004; 89(5):2160–2165.
Samy N, Hashim M, Sayed M, Said M. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers 2009; 26(4):163-70.
Mahabeer S, Naidoo C, Norman RJ, Jialal I, Reddi K, Joubert SM. Metabolic profiles and lipoprotein lipid concentrations in non-obese and obese patients with polycystic ovarian disease. Horm Metab Res 1990;22(10):537-40.
Anuradha Kalra, Sreekumaran Nair, Lavanya Rai. Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome. Indian J Med Sci 2006;60:
-53.
Ford ES. The metabolic syndrome and mortality from cardio vascular disease and all-causes: finding from the National Health and Nutrition Examination Survey II Mortality study. Atherosclerosis 2004;173:307-312.
Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, et al. The metabolic syndrome, circulating oxidized LDL and risk of myocardial infarction in well- functioning elderly people in the health, ageing and body composition. Diabetes 2004;53(4):1068-1073.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–502
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28(7):412–9.
Mukherjee S, Maitra A. Molecular and genetic factors contributing to insulin resistance in polycystic ovary syndrome. Indian J Med Res 2010;131:743-760.
Dunaif A, Xia J, Book CB, Schenker E and Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest 1995;96:801- 810.
Rosenbaum D, Haber RS, Dunaif A. Insulin resistance in polycystic ovary syndrome: ecreased expression of GLUT4 glucose transporters in adipocytes. Am J Physiol 1993;264:197- 202.
Talbot JA, Bicknell EJ, Rajkhowa M, Krook A, O’Rahilly S, Clayton RN. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 1996;81(5):1979-83
Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol 2000;52(5):595–600.
Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. irculation 2002;105:546–549.
Oh JY, Lee JA, Lee H, Oh JY, Sung YA, and Chung H. Serum C-Reactive Protein Levels in Normal Weight Polycystic Ovary Syndrome. Korean J Intern Med 2009;24(4):350-355.
Saijo Y, Kiyota N, Kawasaki Y, Miyazaki Y, Kashimura J, Fukuda M, et al. Relationship between C reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab 2004;6(4):249-258.
Pieroni L, Bastard JP, Piton A, Khalil L, Hainque B, Jardel C. Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diabetes Metab 2003;29:133-138.
Campos SP, Baumann H. Insulin is a prominent modulator of the cytokine- stimulated expression of acute-phase plasma protein genes. Mol Cell Biol 1992;12(4):1789-97.
Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-3421.
Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 2007;18(7):280-285.
Wetterau JR, Lin MC, Jamil H. Microsomal triglyceride transfer protein. Biochim Biophys Acta 1997;1345:136-150.
